Proteon logo     Print Page | Close Window

SEC Filings

S-1
PROTEON THERAPEUTICS INC filed this Form S-1 on 09/16/2014
Entire Document
 

 

PROTEON THERAPEUTICS, INC.

 

Fourth Amended and Restated Investors’ Rights Agreement

 

Investor Signature Page

 

By executing this page in the space provided, the undersigned hereby agrees (i) that he, she or it is an “Investor” as defined in the Fourth Amended and Restated Investors’ Rights Agreement dated as of May 13, 2014, as amended and in effect from time to time (the “Investors’ Rights Agreement”), by and among Proteon Therapeutics, Inc. and the parties named therein, (ii) that he, she or it is a party to the Investors’ Rights Agreement for all purposes and (iii) that he, she or it is bound by all terms and conditions of the Investors’ Rights Agreement.

 

EXECUTED this 13th day of May, 2014.

 

 

 

Prism Venture Partners V-A, L.P.

 

By:

Prism Investment Partners V, L.P.

 

 

its General Partner

 

 

 

 

By:

Prism Venture Partners V, L.L.C.

 

 

its General Partner

 

 

 

 

 

 

 

By:

/s/ Brendan O’Leary

 

 

 

 

Title:

Managing Director

 

NOTE NEW ADDRESS:

 

 

75 Second Avenue, Suite 210

Address:

117 Kendrick Street, Suite 200

 

Needham, MA 02494

 

 

 

 

 

Needham, MA 02494

 

 

 

 

 

 

 

Email:

 

 

 

 

 

Fax:

 

 

[SIGNATURE PAGE TO THE PROTEON THERAPEUTICS, INC.

FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT]